BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Syoligo, a Sylentis project - ECPv6.9.0//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://syoligo.sylentis.com
X-WR-CALDESC:Events for Syoligo, a Sylentis project
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260224
DTEND;VALUE=DATE:20260226
DTSTAMP:20260801T114041
CREATED:20260121T085546Z
LAST-MODIFIED:20260122T071856Z
UID:894-1771891200-1772063999@syoligo.sylentis.com
SUMMARY:TIDES ASIA\, Tokyo
DESCRIPTION:Further information: TIDES Asia: Oligonucleotide & Peptide Therapeutics\nAna Isabel Jiménez and Pablo Lores will be representing Sylentis. Pablo will give two lectures: \n“Phase-appropriate CMC considerations for next generation oligonucleotides” \n“Lessons learned building an oligo CMC program for small company: doing more with less”
URL:https://syoligo.sylentis.com/event/tides-asia-tokyo/
ATTACH;FMTTYPE=image/jpeg:https://syoligo.sylentis.com/wp-content/uploads/2026/01/Untitled-design.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260317
DTEND;VALUE=DATE:20260320
DTSTAMP:20260801T114041
CREATED:20260121T085758Z
LAST-MODIFIED:20260122T071643Z
UID:899-1773705600-1773964799@syoligo.sylentis.com
SUMMARY:RNA Leaders Europe\, Vienna
DESCRIPTION:Further information: RNA Therapeutics & Vaccines | RNA Leaders Europe\nPablo Lores will attend on behalf of Sylentis.
URL:https://syoligo.sylentis.com/event/rna-leaders-europe-vienna/
ATTACH;FMTTYPE=image/jpeg:https://syoligo.sylentis.com/wp-content/uploads/2026/01/Untitled-design-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260511
DTEND;VALUE=DATE:20260515
DTSTAMP:20260801T114041
CREATED:20260121T090850Z
LAST-MODIFIED:20260122T071430Z
UID:904-1778457600-1778803199@syoligo.sylentis.com
SUMMARY:TIDES USA\, Boston
DESCRIPTION:Further information: TIDES USA 2026: Oligonucleotide and Peptide Therapeutics\nSylentis is a sponsor\nLola Company and Pablo Lores will attend\, with the latter giving a talk entitled “Manufacturing Aspects o and IND”
URL:https://syoligo.sylentis.com/event/tides-usa-boston/
ATTACH;FMTTYPE=image/jpeg:https://syoligo.sylentis.com/wp-content/uploads/2026/01/Untitled-design-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260609
DTEND;VALUE=DATE:20260612
DTSTAMP:20260801T114041
CREATED:20260121T091447Z
LAST-MODIFIED:20260122T071248Z
UID:909-1780963200-1781222399@syoligo.sylentis.com
SUMMARY:International Oligonucleotides and peptides conference\, Athens
DESCRIPTION:Further information: HOME – IOPC\nPablo Lores will attend on behalf of Sylentis.
URL:https://syoligo.sylentis.com/event/international-oligonucleotides-and-peptides-conference-athens/
ATTACH;FMTTYPE=image/jpeg:https://syoligo.sylentis.com/wp-content/uploads/2026/01/Untitled-design-1-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260825
DTEND;VALUE=DATE:20260829
DTSTAMP:20260801T114041
CREATED:20260121T092110Z
LAST-MODIFIED:20260122T070958Z
UID:914-1787616000-1787961599@syoligo.sylentis.com
SUMMARY:International Round Table on Nucleosides\, Nucleotides and Nucleic Acids\, Barcelona\,
DESCRIPTION:Further information: IRT 2026\nSylentis is a sponsor\nLola Company and Pablo Lores will attend on behalf of Sylentis
URL:https://syoligo.sylentis.com/event/international-round-table-on-nucleosides-nucleotides-and-nucleic-acids-barcelona/
ATTACH;FMTTYPE=image/jpeg:https://syoligo.sylentis.com/wp-content/uploads/2026/01/Untitled-design-3.jpg
END:VEVENT
END:VCALENDAR